Skip to main content

Glen Eagle Advisors, LLC

SEC CIK
0002029317
Latest filing
Aug 14, 2026

WST holding history

West Pharmaceutical Services Inc in every 13F filed by Glen Eagle Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

WST overviewAll 13F holders of WSTFull Q2 2026 holdings

Shares (Q2 2026)
113
Value
$40.6K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of WST by Glen Eagle Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026113$40.6K<0.1%+3+2.7%AddedHolders
Q1 2026110$27.6K<0.1%00.0%UnchangedHolders
Q4 2025110$30.3K<0.1%00.0%UnchangedHolders
Q3 2025110$28.9K<0.1%00.0%UnchangedHolders
Q2 2025110$24.1K<0.1%00.0%UnchangedHolders
Q1 2025110$24.6K<0.1%00.0%UnchangedHolders
Q4 2024110$36.0K<0.1%00.0%UnchangedHolders
Q3 2024110$33.0K<0.1%00.0%UnchangedHolders
Q2 2024110$36.2K<0.1%00.0%UnchangedHolders
Q1 2024110$43.5K<0.1%00.0%UnchangedHolders
Q4 2023110$38.7K<0.1%00.0%UnchangedHolders
Q3 2023110$41.3K<0.1%00.0%UnchangedHolders
Q2 2023110$42.1K<0.1%00.0%UnchangedHolders
Q1 2023110$38.1K<0.1%00.0%UnchangedHolders
Q4 2022110$25.9K<0.1%00.0%UnchangedHolders
Q3 2022110$27.1K<0.1%00.0%UnchangedHolders
Q2 2022110$33.3K<0.1%00.0%UnchangedHolders
Q1 2022110$45.2K<0.1%00.0%UnchangedHolders
Q4 2021110$51.6K<0.1%00.0%UnchangedHolders
Q3 2021110$46.7K<0.1%00.0%UnchangedHolders
Q2 2021110$39.5K<0.1%00.0%UnchangedHolders
Q1 2021110$31.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.